Cigna Corp (CI · NYSE)
CI · MARKET VIEW
Market view · as of Sep 14, 2026
Revenue (TTM)
$282.38B
+6.7% YoY
Gross margin
9.1%
EPS (latest q)
$7.78
vs $7.58 est · beat
52-wk position
64.1%
-7.7% vs 52w high · +1.6% 1mo
Price (last ~year)
Cigna Corp (CI) has exceeded analyst earnings estimates in each of the last four quarters, most recently posting $7.78 per share for the period ending June 30, 2026. The company reported $282.38 billion in trailing twelve-month revenue, a 6.7% year-over-year increase, while earnings grew 10.2% over the same period. With a market capitalization of $74.19 billion and a P/E ratio of 11.62, the firm carries $31.88 billion in total debt against $6.30 billion in cash.
Valuation
- Market cap
- $74.19B
- P/E
- 11.62
- PEG
- 0.764
- P/B
- 1.741
- P/S
- 0.263
- EV/EBITDA
- 7.74
- Beta
- 0.317
- Analyst target
- $339.36
Quality & returns
- Gross margin
- 9.1%
- Operating margin
- 4.0%
- Profit margin
- 2.3%
- ROE
- 16.8%
- ROA
- 4.5%
Price movement
- Last
- $280.76
- 1-month
- +1.6%
- 3-month
- -3.3%
- RSI (14)
- 56
- vs SMA200
- +1.5%
- 52-wk position
- 64.1% -7.7% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $71.67B | $2.68B | $1.66B | $2.61B |
| 2026-03-31 | $68.49B | $2.36B | $1.65B | $3.28B |
| 2025-12-31 | $72.47B | $2.15B | $1.23B | $2.54B |
| 2025-09-30 | $69.75B | $2.58B | $1.87B | $3.34B |
Recent news
- Somewhat-Bullish BMO commits $70 billion in new spending to help build Canadian industry · 2026-09-11
- Somewhat-Bullish Caring Brands, Inc. Announces Appointment of Brian R. Meadows as Director, Effective September 4, 2026 · 2026-09-10
- Neutral Evolution Petroleum Keeps Quarterly Dividend at $0.12 a Share, Payable Sept. 30 to Stockholders of Record Sept. 21. · 2026-09-10
- Neutral Transcript : Novavax, Inc. Presents at Citigroup’s Biopharma Back to School Summit 2026, Sep-10-2026 10 · 2026-09-10
- Neutral SKYX Platforms Corp. entered into a definitive agreement to acquire Deako, Inc. for $46.25 million. · 2026-09-10
- Neutral Alumis Insider Bought Shares Worth $10,726,255, According to a Recent SEC Filing · 2026-09-10
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)